Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celetrix is a private life science tools company focused on electroporation instruments, consumables, and related development services for biotech companies and research institutions. The company commercializes high-efficiency electroporation technologies used for cell engineering workflows including gene editing, CAR-T and CAR-NK preparation, stable cell line development, antibody transient expression, cell fusion, and bacterial or yeast electroporation. Its product lineup includes electroporator models such as SP100, LE+, EX+, and SLT, along with the proprietary Celetrix electroporation tube and application-specific kits such as a THP-1 helper kit. Rather than developing therapeutics of its own, Celetrix appears to operate as a commercial tools and services provider that supports cell therapy, biologics discovery, and research workflows. The company was founded in Virginia in 2012 and is headquartered in Manassas, Virginia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celetrix.